These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1505649)

  • 21. Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Al Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al Tamimi O; Alawadhi M
    Curr Med Res Opin; 2014 Dec; 30(12):2429-35. PubMed ID: 25222765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of triglycerides in atherosclerosis.
    Talayero BG; Sacks FM
    Curr Cardiol Rep; 2011 Dec; 13(6):544-52. PubMed ID: 21968696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
    Valensi P
    Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
    Siegel RD; Cupples A; Schaefer EJ; Wilson PW
    Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyslipidemia in type II diabetes. Implications for therapeutic intervention.
    Stern MP; Haffner SM
    Diabetes Care; 1991 Dec; 14(12):1144-59. PubMed ID: 1773701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinofibrate therapy raises high-density lipoprotein levels and lowers atherogenic index in diabetes mellitus patients.
    Okada S; Miyai Y; Ichiki K; Sato K; Masaki Y; Higuchi T; Ogino Y; Ota Z
    J Int Med Res; 1989; 17(6):521-5. PubMed ID: 2628128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
    Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
    Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular disease.
    Vogelberg KH; Grimm K; Gries FA
    Horm Metab Res Suppl; 1985; 15():90-4. PubMed ID: 3865888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.
    Chaturvedi N; Fuller JH; Taskinen MR;
    Diabetes Care; 2001 Dec; 24(12):2071-7. PubMed ID: 11723085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease.
    Kumar V; Madhu SV; Singh G; Gambhir JK
    J Assoc Physicians India; 2010 Oct; 58():603-7. PubMed ID: 21510110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic control and the prevalence of dyslipidemia in children and adolescents with insulin-dependent diabetes mellitus].
    Torres Tamayo M; Lerman Garber I; Bravo Ríos LE; Cardoso Saldaña G; Mendoza Morfín F; Zamora González J; Montero González P; Junco Lorenzana E; Posadas Romero C
    Rev Invest Clin; 1993; 45(6):545-52. PubMed ID: 8159874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Diabetologia; 1993 Nov; 36(11):1175-84. PubMed ID: 8270133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?
    Kumar A; Singh V
    Vasc Health Risk Manag; 2010 Sep; 6():665-9. PubMed ID: 20859538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid abnormalities in Greek patients with coronary artery disease.
    Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA
    Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2011 Jul; 108(1):40-6. PubMed ID: 21565322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.
    Connor WE; DeFrancesco CA; Connor SL
    Ann N Y Acad Sci; 1993 Jun; 683():16-34. PubMed ID: 8352438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.